Double-blind comparison of iodamide and diatrizoate for excretory urography.

They found no correlation with sex or age of the patient. Other studies of iodamide have found a variable incidence of adverse reaction [4,5,6] but none of these represented a comparative trial with another agent. The data of our clinical trial indicates that the two agents are equal for parenchy- mal opacification but that iodamide is superior for opacifying the calices and pelvis. For the ureters and bladder, there is a clear trend towards superior performance by iodamide but not with the same degree of statistical confidence as was demonstrated for the calices and pelvis.

also in 12,136 other papers

ne (0) 2 1 0 0 1 1 3 2 0 0 20 Dense (2) 5 0 13 9 15 11 9 4 15* 13 Faint (1) 9 16 5 8 2 6 8 12 3 2 None (0) 4 1 0 0 1 0 1 1 0 2 30 Dense (2) 4 2 13 10 16* 10 10 4 20 19 Faint (1) 15 20 10 12 7 13 12 18 2 4 None (0) 4 2 0 2 0 1 1 2 1 1 * = p <.05 ** = p <.01 Note: At all sites there is a definite trend toward denser opacification with iodamide than with Renografin.

also in 240 other papers